Study Comparing the Effectiveness of Cosmetic Product RV4133C With a Moisturizing Cream in Treating Facial Acne in Teens and Young Adults Over 6 Months

What this Trial Is About

Researchers are evaluating the overall benefit and tolerance of a cosmetic product called RV4133C - Formula JT2559 as complementary care alongside a topical medical treatment for facial acne. This study focuses on teenagers and young adults aged 14 to 24 with mild to moderate acne, comparing the tested product to a light moisturizing cream over two phases a 3-month associated treatment phase plus a 3-month maintenance phase. Participants will apply either the tested cosmetic product or a comparator moisturizing cream twice daily to the entire face while using the prescribed topical medical treatment during the first 3 months. After this associated treatment phase, they will continue applying the product alone for an additional 3 months during the maintenance phase. The study is randomized and investigator-blinded, aiming to assess efficacy and tolerance throughout these 6 months. During the study, researchers will evaluate the number of total acne lesions after 24 weeks, along with multiple other measures including Investigators Global Assessment, lesion counts at several timepoints, quality of life questionnaires, and assessments of post-inflammatory hyperpigmentation and erythema. Tolerance, patient satisfaction, compliance, and acne relapse will also be monitored. Participants can expect regular visits for assessments and questionnaires over the full 6-month study period.

A Comparative Study of Cosmetic Product in Subjects With Facial Acne During an Associated-treatment Phase Followed by a Maintenance Phase